Skip to main content

Table 6 Outcome Data

From: The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery

 

MB Group

n = 311

Non-MB Group

n = 202

p-value

30-Day Mortality

57 [18]

10 [5]

0.001

Stay

ICU [d]

26 ± 29

16 ± 16

0.001

IMC [d]

15 ± 18

6 ± 8

0.001

GW [d]

6 ± 19

4 ± 7

n.s.

Renal Failure

130 [42]

30 [15]

0.001

Renal Replacement Therapy

149 [48]

34 [17]

0.001

Respiratory Failure

81 [27]

6 [3]

0.001

Liver Failure

22 [7]

4 [2]

0.007

First Defecation [d]

3.6 ± 2.2

2.3 ± 1.8

0.001

Cerebrovascular Events

44 [15]

10 [5]

0.001

Multi-Organ Failure

40 [13]

8 [4]

0.001

Sepsis

26 [9]

9 [45]

n.s.

TISS10

172

163

 

 ADM

23.2 ± 8.7

20.1 ± 6.9

0.001

 MAXIMUM

30.2 ± 6.8

24.2 ± 6.6

0.001

SAPSII

140

163

 

 ADM

24.19 ± 13.62

21.91 ± 12.13

n.s.

 MAXIMUM

35.52 ± 17.85

46.18 ± 252.34

n.s.

Ventilation Time [h]

246 ± 900

60 ± 101

0.001

Vasopressor-Free Days in ICU [d]

12.3 ± 26.8

11.0 ± 12.4

n.s.

  1. ICU Intensive care unit, IMC Intermediate care unit, GW General ward, TISS Therapeutic intervention scoring system, SAPSII Simplified acute physiology score. All data are presented as number [%] or mean +/− SD. n.s.: not significant